Prenatal complications, genetic vulnerability, and schizophrenia: the new england longitudinal studies of schizophrenia

Psychiatric Annals

Volumn 29, Issue 3, 1999, Pages 151-156

  Buka, Stephen L ^a   Goldstein, Jill M ^b   Seidman, Larry J ^b   Zornberg, Gwen L ^b   Donatelli, Jo Ann A ^b   Denny, Lisa R ^b   Tsuang, Ming T ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033448136     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19990301-11     Document Type: Article

References (67)

1. Gottesman II. Schizophrenia Genesis: The Origin of Madness. New York: Freeman; 1991.
2. Faraone SV, Tsuang MT. Quantitative models of the genetic transmission of schizophrenia. Psychol Bull. 1985;98:41-66.
3. Tsuang MT, Faraone SV. The case for heterogeneity in the etiology of schizophrenia. Schizophr Res. 1995;17: 161-175.
4. Pulver AE, Karayiorgou M, Wolyniec PS, et al. Sequential strategy to identify a susceptibility gene for schizophrenia on chromosome 22q12-q13.1: part 1. Am J Med Genet Neuropsychiatrie Genet. 1994;54:36-43.
5. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. Additional support for schizophrenia linkage on chromosomes 6 and 8. Am J Med Genet. 1996;67:580-594.
6. McGuffin P, Farmer A, Gottesman II. Is there really a split in schizophrenia? The genetic evidence. Br J Psychiatry. 1987;150:581-592.
7. Faraone SV, Lyons MJ, Tsuang MT. Mathematical models of genetic transmission. In: Tsuang MT, Simpson JC, eds. Nosology, Epidemiology and Genetics. Amsterdam: Elsevier; 1988:501-530. (Nasrallah HA, ed. Handbook of Schizophrenia, vol. 3.)
8. Risch N. Linkage strategies for genetically complex traits. Am J Hum Genet. 1990;46:222-228.
9. Kunugi H, Nanko S, Takei N, Saito K, Muray R, Hirose T. Perinatal complications and schizophrenia. J Nerv Ment Dis. 1996;184:542-546.
10. Hultman CM, Ohman A, Cnattingius S, Wieselgren IM, Lindstrom LH. Prenatal and neonatal risk factors for schizophrenia. Br J Psychiatry. 1997;170:128-133.
11. Wright P, Takei N, Rifkin L, Murray RM. Maternal influenza, obstetric complications, and schizophrenia. Am J Psychiatry. 1995;152:1714-1720.
12. Smith GN, Honer WG, Kopala L, MacEwan GW, Altman S, Smith A. Obstetric complications and severity of illness in schizophrenia. Schizophr Res. 1995;14:113-120.
13. Cannon TD. Abnormalities of brain structure and function in schizophrenia: implications for aetiology and pathophysiology. Finnish Medical Society Annals of Medicine. 1996;28:533-539.
14. Jones PB, Rantakallio P, Hartikainen AL, Isohanni M, Sipila P. Schizophrenia as a long-term outcome of pregnancy, delivery and perinatal complications: a 28-year follow-up. Am J Psychiatry. 1998;55:355-364.
15. Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta-analysis. Br J Psychiatry. 1995;67:786-793.
16. Buka SL, Lipsitt LP, Tsuang MT. Perinatal complications and psychiatric diagnosis. Arch Gen Psychiatry. 1993; 50:151-156.
17. Cannon TD, Bearden C, Hollister JM, Hadley T. A prospective cohort study of childhood cognitive deficits as precursors of schizophrenia. Schizophr Res. 1997;24:99.
18. McNeil TF. Obstetric complications in schizophrenic parents. Schizophr Res. 1991;5:89-101.
19. Sacker A, Done D, Crow TJ. Obstetric complications in children born to parents with schizophrenia: a metaanalysis of case-control studies. Psychol Med. 1996;26:279-287.
20. Goodman R. Are complications of pregnancy and birth causes of schizophrenia? Dev Med Child Neurol. 1988;30:391-395.
21. Gunther-Genta F, Bovet P, Hohlfeld P. Obstetric complications and schizophrenia: a case-control study. Br J Psychiatry. 1994;164:165-170.
22. McNeil TF, Cantor-Graae E, Blennow G. Do 'clumsy' fetuses cause labor and delivery complications? A study of offspring at risk for psychosis. Schizophr Res. 1996;22: 85-88.
23. McNeil TF. Perinatal risk factors and schizophrenia: selected review and methodological concerns. Epidemiol Rev. 1995;17:107-112.
24. Mednick SA, Parnas J, Schulsinger F. The Copenhagen High-Risk Project: 1962-1986. Schizophr Bull. 1987;13: 485-495.
25. Dassa D, Sham PC, van Os J, Abel K, Jones P, Murray R. Relationship of birth season to clinical features, family history and obstetric complications in schizophrenia. Psychiatry Res. 1996;64:11-17.
26. McNeil TF, Cantor-Graae E, Nordstrom LG, Rosenlund T. Head circumference in "preschizophrenic" and control neonates. Br J Psychiatry. 1993; 62:517-523.
27. Kunugi H, Takei N, Saito K, Akizuki S, Murray RM, Nanko S. Relationship between impairment of prenatal brain growth and family history of psychosis in schizophrenia. J Psychiatr Res. 1996;30:475-481.
28. Seidman LJ. The neuropsychology of schizophrenia: a neurodevelopmental and case study approach. J Neuropsychiatry Clin Neurosci. 1990;2:301-312.
29. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-669.
30. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophr Bull. 1993;19:431-445.
31. Shenton ME, Wible CG, McCarley RW. A review of magnetic resonance imaging studies of brain abnormalities in schizophrenia. In: Krishnan K, Doraiswamy P, eds. Brain Imaging in Clinical Psychiatry. New York: Marcel Dekker; 1997.
32. Lipska BK, Weinberger DR. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced Stereotypie behaviors in the rat. Developmental Brain Research. 1993;75:213-222.
33. Coyle J. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry. 1996;3:241-253.
34. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett. 1980;20:379-383.
35. Olney J, Farber N. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.
36. Wyatt RJ. Early intervention for schizophrenia: can the course of the illness be altered? Biol Psychiatry. 1995;38:1-3.
37. Rapoport JL, Giedd J, Kumra S, et al. Childhood-onset schizophrenia: progressive ventricular change during adolescence. Arch Gen Psychiatry. 1997;54:897-903.
38. Gur RE, Cowell P, Turetsky BI, et al. A follow-up magnetic resonance imaging study of schizophrenia. Arch Gen Psychiatry. 1998;55:145-152.
39. Fish B, Marcus J, Hans SL, Auerbach JG, Perdue S. Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. Arch Gen Psychiatry. 1992; 49:221-235.
40. Erlenmeyer-Kimling L, Cornblatt BA. Summary of attentional findings in the New York high-risk project. J Psychiatr Res. 1992;26:405-426.
41. Cornblatt B, Winters L, Erlenmeyer-Kimling L. Attentional markers of schizophrenia: evidence from the New York high-risk study. In: Schulz SC, Tamminga CA, eds. Schizophrenia: Scientific Progress. New York: Oxford University Press; 1989:83-92.
42. Nuechterlein KH. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. J Abnorm Psychol. 1983;92:4-28.
43. Rutschmann J, Cornblatt BA, Erlenmeyer-Kimling L. Auditory recognition memory in adolescents at risk for schizophrenia: report on a verbal continuous recognition task. Psychiatry Res. 1980;3:151-161.
44. Harvey P, Winters K, Weintraub S, Neale JM. Distractibility in children vulnerable to psychopathology. J Abnorm Psychol. 1981;90:298-304.
45. Asarnow JR, Goldstein MJ. Schizophrenia during adolescence and early adulthood: a developmental perspective on risk research. Clin Psychol Rev. 1986;6:211-235.
46. Orvaschel H, Mednick S, Schulsinger F, Rock D. The children of psychiatrically disturbed parents: differences as a function of the sex of the sick parent. Arch Gen Psychiatry. 1979;36:691-695.
47. Lifshitz M, Kugelmass S, Karov M. Perceptual-motor and memory performance of high-risk children. Schizophr Bull. 1985;11:74-84.
48. Marcus J, Hans SL, Nagler S, Auerbach JG, Mirsky AF, Aubrey A. Review of the NIMH Israeli kibbutz-city study and the Jerusalem infant development study. Schizophr Bull. 1987;13:425-438.
49. Auerbach J, Hans S, Marcus J. Neurobehavioral functioning and social behavior of children at risk for schizophrenia. Isr J Psychiatry Relat Sci. 1993;30:40-49.
50. Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Lyons MJ, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients. J Abnorm Psychol. 1995;104:286-304.
51. Cannon TD, Marco E. Structural brain abnormalities as indicators of vulnerability to schizophrenia. Schizophr Bull. 1994;20:89-102.
52. Kremen WS, Seidman LJ, Pepple JR, Lyons MJ, Tsuang MT, Faraone SV. Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull. 1994;20:103-119.
53. Seidman LJ. Clinical neuroscience and epidemiology of schizophrenia. Harv Rev Psychiatry. 1997;3:338-342.
54. Seidman LJ, Faraone SV, Goldstein JG, et al. Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: a pilot MRI study. Am J Med Genet. 1997;74:498-505.
55. Lenzemveger MF. Psychometric high-risk paradigm, perceptual aberrations, and schizotypy: an update. Schizophr Bull. 1994;20:121-136.
56. Levy DL, Holzman PS, Matthysse S, Mendell NR. Eye tracking and schizophrenia: a selective review. Schizophr Bull. 1994;20:47-62.
57. Comblatt BA, Keilp JG. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull. 1994;20:31-46.
58. Shenton ME, Solovay MR, Holzman PS, Coleman M, Gale HJ. Thought disorder in the relatives of psychotic patients. Arch Gen Psychiatry. 1989;46:897-901.
59. Catts SV, McConaghy N, Ward PB, Fox AM, Hadzi-Pavlovic D. Allusive thinking in parents of schizophrenics: meta-analysis. J Nerv Ment Dis. 1993;181:298-302.
60. Erlenmeyer-Kimling L, Cornblatt B, et al. Neurological electrophysiological and attentional deviations in children at risk for schizophrenia. In: Henn FA, Nasrallah HA, eds. Schizophrenia as a Brain Disease. New York: Oxford: University Press; 1982.
61. Friedman D, Squires-Wheeler E. Event-related potentials (ERPs) as indicators of risk for schizophrenia. Schizophr Bull. 1994;20:63-74.
62. Leonard S, Adams C, Breese CR, et al. Nicotinic receptor function in schizophrenia. Schizophr Bull. 1996;22:431-445.
63. Faraone SV, Kremen WS, Lyons MJ, Pepple JR, Seidman LJ, Tsuang MT. Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes? Am J Psychiatry. 1995;152:1286-1290.
64. Buka SL, Goldstein JM, Seidman LJ, Zornberg GL, Denny LR, Tsuang MT. Chronic fetal hypoxia and other obstetric risk factors for psychotic illness: a replication study. Schizophr Bull. 1998. In press.
65. Zornberg G. Identifying critical periods of neurodevelopmental risk: the turning point in schizophrenia research. Harv Rev Psychiatry. 1998;6:171-174.
66. Zornberg GL, Buka SL, Tsang MT. Fetal and neonatal complications and schizophrenia: reconceiving the neurodevelopmental paradigm. Submitted for publication.
67. Buka SL, Goldstein JM, Seidman LJ, Zornberg GL, Denny LR, Tsuang MT. Chronic fetal hypoxia and other obstetric risk factors for psychotic illness: a replication study. Schizophr Res. 1998;29:13.